{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T17:40:20Z","timestamp":1648662020969},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T00:00:00Z","timestamp":1353456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00405-012-2269-z","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T19:32:28Z","timestamp":1353612748000},"page":"2433-2438","source":"Crossref","is-referenced-by-count":1,"title":["DNA copy gains of tumor-related genes in vestibular schwannoma"],"prefix":"10.1007","volume":"270","author":[{"given":"Luis","family":"Lassaletta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Torres-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"San-Rom\u00e1n-Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier S.","family":"Castresana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Gavil\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,21]]},"reference":[{"key":"2269_CR1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"DJ Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA et al (1989) Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science 244:707\u2013712","journal-title":"Science"},{"key":"2269_CR2","first-page":"4087","volume":"50","author":"A Berchuck","year":"1990","unstructured":"Berchuck A, Kamel A, Whitaker R et al (1990) Overexpression of HER-2\/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50:4087\u20134091","journal-title":"Cancer Res"},{"key":"2269_CR3","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/modpathol.3800695","volume":"19","author":"JJ Abbott","year":"2006","unstructured":"Abbott JJ, Erickson-Johnson M, Wang X et al (2006) Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Mod Pathol 19:1512\u20131518","journal-title":"Mod Pathol"},{"key":"2269_CR4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2990.2005.00653.x","volume":"31","author":"D Arjona","year":"2005","unstructured":"Arjona D, Bello MJ, Alonso ME et al (2005) Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations. Neuropathol Appl Neurobiol 31:384\u2013394","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2269_CR5","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1309\/448YRWNC43TE32KQ","volume":"123","author":"ME Alonso","year":"2005","unstructured":"Alonso ME, Bello MJ, Arjona D, Martinez V et al (2005) Real-time quantitative PCR analysis of gene dosages reveals gene amplification in low-grade oligodendrogliomas. Am J Clin Pathol 123:900\u2013906","journal-title":"Am J Clin Pathol"},{"key":"2269_CR6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cancergencyto.2006.09.023","volume":"173","author":"C Franco-Hernandez","year":"2007","unstructured":"Franco-Hernandez C, Martinez-Glez V, Arjona D et al (2007) EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors. Cancer Genet Cytogenet 173:63\u201367","journal-title":"Cancer Genet Cytogenet"},{"key":"2269_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/hmg\/3.1.147","volume":"3","author":"EC Twist","year":"1994","unstructured":"Twist EC, Ruttledge MH, Rousseau M et al (1994) The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147\u2013151","journal-title":"Hum Mol Genet"},{"key":"2269_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/gcc.2870130311","volume":"13","author":"P M\u00e9rel","year":"1995","unstructured":"M\u00e9rel P, Hoang-Xuan K, Sanson M et al (1995) Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosom Cancer 13:211\u2013216","journal-title":"Genes Chromosom Cancer"},{"key":"2269_CR9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cell.2010.01.029","volume":"140","author":"W Li","year":"2010","unstructured":"Li W, You L, Cooper J, Schiavon G et al (2010) Merlin\/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell 140:477\u2013490","journal-title":"Cell"},{"key":"2269_CR10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/onc.2008.427","volume":"28","author":"D Lallemand","year":"2009","unstructured":"Lallemand D, Manent J, Couvelard A et al (2009) Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas. Oncogene 28:854\u2013865","journal-title":"Oncogene"},{"key":"2269_CR11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/sj.onc.1209849","volume":"26","author":"Y Bai","year":"2007","unstructured":"Bai Y, Liu YJ, Wang H et al (2007) Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Oncogene 26:836\u2013850","journal-title":"Oncogene"},{"key":"2269_CR12","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1128\/MCB.01392-08","volume":"29","author":"SS Houshmandi","year":"2009","unstructured":"Houshmandi SS, Emnett RJ, Giovannini M et al (2009) The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner. Mol Cell Biol 29:1472\u20131486","journal-title":"Mol Cell Biol"},{"key":"2269_CR13","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1158\/0008-5472.CAN-08-3931","volume":"69","author":"M Okada","year":"2009","unstructured":"Okada M, Wang Y, Jang SW et al (2009) Akt phosphorylation of merlin enhances its binding to phosphatidylinositols and inhibits the tumor-suppressive activities of merlin. Cancer Res 69:4043\u20134051","journal-title":"Cancer Res"},{"key":"2269_CR14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200703010","volume":"177","author":"M Curto","year":"2007","unstructured":"Curto M, Cole BK, Lallemand D et al (2007) Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin. J Cell Biol 177:893\u2013903","journal-title":"J Cell Biol"},{"key":"2269_CR15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ng930","volume":"31","author":"C Fernandez-Valle","year":"2002","unstructured":"Fernandez-Valle C, Tang Y, Ricard J et al (2002) Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat Genet 31:354\u2013362","journal-title":"Nat Genet"},{"key":"2269_CR16","first-page":"32","volume":"1785","author":"DR Scoles","year":"2008","unstructured":"Scoles DR (2008) The merlin interacting proteins reveal multiple targets for NF2 therapy. Biochim Biophys Acta 1785:32\u201354","journal-title":"Biochim Biophys Acta"},{"key":"2269_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ncb1339","volume":"8","author":"F Hamaratoglu","year":"2006","unstructured":"Hamaratoglu F, Willecke M, Kango-Singh M et al (2006) The tumour-suppressor genes NF2\/Merlin and expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol 8:27\u201336","journal-title":"Nat Cell Biol"},{"key":"2269_CR18","first-page":"5601","volume":"9","author":"P Gonzalez-Gomez","year":"2001","unstructured":"Gonzalez-Gomez P, Bello MJ, Alonso ME et al (2001) CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas. Clin Cancer Res 9:5601\u20135606","journal-title":"Clin Cancer Res"},{"key":"2269_CR19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cancergencyto.2006.02.022","volume":"172","author":"MJ Bello","year":"2007","unstructured":"Bello MJ, Martinez-Glez V, Franco-Hernandez C et al (2007) DNA methylation pattern in 16 tumor-related genes in schwannomas. Cancer Genet Cytogenet 172:84\u201386","journal-title":"Cancer Genet Cytogenet"},{"key":"2269_CR20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/01.mao.0000226291.42165.22","volume":"27","author":"L Lassaletta","year":"2006","unstructured":"Lassaletta L, Bello MJ, Del R\u00edo L et al (2006) DNA methylation of multiple genes in vestibular schwannoma: relationship with clinical and radiological findings. Otol Neurotol 27:1180\u20131185","journal-title":"Otol Neurotol"},{"key":"2269_CR21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/MAO.0b013e31814b2285","volume":"28","author":"L Lassaletta","year":"2007","unstructured":"Lassaletta L, Patr\u00f3n M, Del R\u00edo L et al (2007) Cyclin D1 expression and histopathologic features in vestibular schwannomas. Otol Neurotol 28:939\u2013941","journal-title":"Otol Neurotol"},{"key":"2269_CR22","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1038\/onc.2010.363","volume":"29","author":"KD Hadfield","year":"2010","unstructured":"Hadfield KD, Smith MJ, Urquhart JE et al (2010) Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene 29:6216\u20136221","journal-title":"Oncogene"},{"key":"2269_CR23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s007010070036","volume":"142","author":"J Antinheimo","year":"2000","unstructured":"Antinheimo J, Sallinen SL, Sallinen P et al (2000) Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH). Acta Neurochir (Wien) 142:1099\u20131104","journal-title":"Acta Neurochir (Wien)"},{"key":"2269_CR24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/jmg.40.11.802","volume":"40","author":"C Warren","year":"2003","unstructured":"Warren C, James LA, Ramsden RT et al (2003) Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet 40:802\u2013806","journal-title":"J Med Genet"},{"key":"2269_CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11060-004-2693-z","volume":"72","author":"T Ikeda","year":"2005","unstructured":"Ikeda T, Hashimoto S, Fukushige S et al (2005) Comparative genomic hybridization and mutation analyses of sporadic schwannomas. J Neurooncol 72:225\u2013230","journal-title":"J Neurooncol"},{"key":"2269_CR26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11060-010-0412-5","volume":"103","author":"D Koutsimpelas","year":"2011","unstructured":"Koutsimpelas D, Felmeden U, Mann WJ et al (2011) Analysis of cytogenetic aberrations in sporadic vestibular schwannoma by comparative genomic hybridization. J Neurooncol 103:437\u2013443","journal-title":"J Neurooncol"},{"key":"2269_CR27","first-page":"493","volume":"34","author":"V Martinez-Glez","year":"2009","unstructured":"Martinez-Glez V, Franco-Hernandez C, Alvarez L et al (2009) Meningiomas and schwannomas: molecular subgroup classification found by expression arrays. Int J Oncol 34:493\u2013504","journal-title":"Int J Oncol"},{"key":"2269_CR28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.anndiagpath.2006.09.007","volume":"11","author":"RA Prayson","year":"2007","unstructured":"Prayson RA, Yoder BJ, Barnett GH (2007) Epidermal growth factor receptor is not amplified in schwannomas. Ann Diagn Pathol 11:326\u2013329","journal-title":"Ann Diagn Pathol"},{"key":"2269_CR29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00129492-200501000-00017","volume":"26","author":"P Cay\u00e9-Thomasen","year":"2005","unstructured":"Cay\u00e9-Thomasen P, Werther K, Nalla A et al (2005) VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol 26:98\u2013101","journal-title":"Otol Neurotol"},{"key":"2269_CR30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ijc.2910510507","volume":"51","author":"JA Rey","year":"1992","unstructured":"Rey JA, Bello MJ, Jimenez-Lara AM et al (1992) Loss of heterozygosity for distal markers on 22q in human gliomas. Int J Cancer 51:703\u2013706","journal-title":"Int J Cancer"},{"key":"2269_CR31","first-page":"1489","volume":"25","author":"D Arjona","year":"2004","unstructured":"Arjona D, Bello MJ, Alonso ME et al (2004) Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas. Int J Oncol 25:1489\u20131494","journal-title":"Int J Oncol"},{"key":"2269_CR32","first-page":"6091","volume":"59","author":"MJ Riemenschneider","year":"1999","unstructured":"Riemenschneider MJ, B\u00fcschges R, Wolter M et al (1999) Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res 59:6091\u20136096","journal-title":"Cancer Res"},{"key":"2269_CR33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/mao.0b013e31815d4429","volume":"29","author":"JK Doherty","year":"2008","unstructured":"Doherty JK, Ongkeko W, Crawley B, Andalibi A, Ryan AF (2008) ErbB and Nrg: potential molecular targets for vestibular schwannoma pharmacotherapy. Otol Neurotol 29:50\u201357","journal-title":"Otol Neurotol"},{"key":"2269_CR34","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/MAO.0b013e31817f7398","volume":"29","author":"JJ Clark","year":"2008","unstructured":"Clark JJ, Provenzano M, Diggelmann HR et al (2008) The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study. Otol Neurotol 29:846\u2013853","journal-title":"Otol Neurotol"},{"key":"2269_CR35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/glia.20316","volume":"53","author":"MR Hansen","year":"2006","unstructured":"Hansen MR, Roehm PC, Chatterjee P et al (2006) Constitutive neuregulin-1\/ErbB signaling contributes to human vestibular schwannoma proliferation. Glia 53:593\u2013600","journal-title":"Glia"},{"key":"2269_CR36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2005-926216","volume":"16","author":"DM Baguley","year":"2006","unstructured":"Baguley DM, Humphriss RL, Axon PR et al (2006) The clinical characteristics of tinnitus in patients with vestibular schwannoma. Skull Base 16:49\u201358","journal-title":"Skull Base"},{"key":"2269_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0004.2009.01315.x","volume":"77","author":"SK Selvanathan","year":"2010","unstructured":"Selvanathan SK, Shenton A, Ferner R et al (2010) Further genotype\u2013phenotype correlations in neurofibromatosis 2. Clin Genet 77:163\u2013170","journal-title":"Clin Genet"},{"key":"2269_CR38","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/MAO.0b013e3181de46ae","volume":"31","author":"Y Agrawal","year":"2010","unstructured":"Agrawal Y, Clark JH, Limb CJ et al (2010) Predictors of vestibular schwannoma growth and clinical implications. Otol Neurotol 31:807\u2013812","journal-title":"Otol Neurotol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-012-2269-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-012-2269-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-012-2269-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T23:41:39Z","timestamp":1562370099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-012-2269-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,21]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["2269"],"URL":"https:\/\/doi.org\/10.1007\/s00405-012-2269-z","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,21]]}}}